-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Leidos Holdings (LDOS) Below Fair Value Following Its CoreWeave Deal And Air Force Win?

Simply Wall St·08/02/2026 06:14:14
Listen to the news

Leidos Holdings (LDOS) is back in focus after a busy week that included a new sovereign AI cloud alliance with CoreWeave, the Parcata autonomous cybersecurity platform launch, and a large U.S. Air Force ISR task order.

See our latest analysis for Leidos Holdings.

Despite the fresh AI alliance, Parcata launch, and new ISR task order, Leidos Holdings’ share price has been under pressure, with a 90 day share price return down 22.5% and a year to date share price return down 37%, even though the 3 year total shareholder return is 23.2%.

If you are interested in other AI focused opportunities off the back of this news, now could be a time to check out 70 profitable AI stocks that aren't just burning cash

Leidos Holdings now trades well below both its analyst target and an internal fair value estimate range. After the recent share price slide, where does a reasonable value anchor actually sit as investors reassess the story?

Most Popular Narrative: 30.1% Undervalued

Leidos Holdings last closed at $115.60, while the most followed narrative pegs fair value at $165.27, framing the recent share price slide against a higher long run anchor.

Accelerating customer demand for digital modernization, AI-powered solutions, and autonomous systems in defense, healthcare, and intelligence plays to Leidos' strengths and is leading to higher-quality, higher-margin contracts that improve net margins, as these capabilities command premium pricing and are in areas of secular growth.

Read the complete narrative.

Want to understand why this narrative supports a higher value for Leidos Holdings? It leans heavily on steady revenue gains, firm margins, and a future earnings multiple that assumes investors keep paying up for dependable cash flows.

Result: Fair Value of $165.27 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Leidos Holdings still faces meaningful risks if U.S. federal spending priorities shift or if healthcare contracts and acquisitions do not deliver as analysts expect.

Find out about the key risks to this Leidos Holdings narrative.

Next Steps

Given the mix of optimism and concern around Leidos Holdings, this is a good time to review the numbers yourself and move quickly to form your own stance using the full picture of 5 key rewards and 1 important warning sign

Looking for more investment ideas beyond Leidos Holdings?

If Leidos Holdings has your attention, do not stop there. Broaden your watchlist now so you are not the one hearing about the next opportunity after it moves.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.